Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
cancer
3
×
life sciences
national blog main
biotech
boston top stories
foundation medicine
national top stories
new york blog main
andrew berens
avapritinib
beam therapeutics
biotech week boston
blueprint medicines
bristol-myers squibb
broad institute
bwb
cancer immunotherapy
center for medicare and medicaid services
cindy perettie
clinical trials
companion diagnostic
crispr
daniel o'day
david liu
deals
deciphera pharmaceuticals
editas medicine
fda
foundationone cdx
foundationone heme
gastrointestinal stromal tumor
genentech
gist
gleevec
imatinib
immuno-oncology
laurie glimcher
luk vandenberghe
What
medicine
3
×
morning
tumor
acquire
agreed
announced
approval
benefiting
big
billion
blueprint
boston
broad
cancer
chasing
coming
confidence
deadly
deciphera
diagnostics
didn’t
drug
fda
filing
forms
foundation
gain
genentech
gi
glimcher
groundbreaking
headline
keynote
laurie
market
momentum
panels
patients
pay
pays
Language
unset
Current search:
boston
×
cancer
×
medicine
×
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine